Evidence map›Paper›PMID 31579518›Full record

ReviewNeuro-oncology practice2016

Genetic counseling and tumor predisposition in neuro-oncology practice.

Erin M Dunbar, Amanda Eppolito, John W Henson

Abstract readReview
In one paragraph

Review in Neuro-oncology practice, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Bridging pediatric and adult neuro-oncology: Insights into adolescents and young adults (AYA) central nervous system tumors.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Erin M DunbarPiedmont Brain Tumor Center, Piedmont Oncology, Atlanta, Georgia (E.M.D.); Genetic Counseling Service, Piedmont Oncology, Atlanta, Georgia (A.E.); Piedmont Brain Tumor Center, Piedmont Oncology, Atlanta, Georgia (J.W.H.).
Amanda EppolitoPiedmont Brain Tumor Center, Piedmont Oncology, Atlanta, Georgia (E.M.D.); Genetic Counseling Service, Piedmont Oncology, Atlanta, Georgia (A.E.); Piedmont Brain Tumor Center, Piedmont Oncology, Atlanta, Georgia (J.W.H.).
John W HensonPiedmont Brain Tumor Center, Piedmont Oncology, Atlanta, Georgia (E.M.D.); Genetic Counseling Service, Piedmont Oncology, Atlanta, Georgia (A.E.); Piedmont Brain Tumor Center, Piedmont Oncology, Atlanta, Georgia (J.W.H.).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor predisposition syndromes may be under-recognized in neuro-oncology practice. Identifying patients with a hereditary tumor predisposition permits appropriate tumor management as well as surveillance and risk-reduction measures for patients and their families. The American College of Medical Genetics and Genomics and the National Society of Genetic Counselors recently published referral guidelines for tumor predisposition assessment, providing an impetus to review the use of genetic counseling in neuro-oncology and to describe features of the less stereotypic conditions from the perspective of neuro-oncology practice. This review also provides a framework for the identification and management of these conditions, as well as references to guidelines and resources for providers and patients.

Indexed as

brain tumorfamilialgeneticgenetic counselinghereditary

Identifiers

PMID31579518
PMCPMC6760343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.